ArticleCureus2025
Primary Central Nervous System Lymphoma: A Case Report of the Neurological Great Mimicker.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary central nervous system lymphoma (PCNSL) is a rare lymphoproliferative disorder that primarily affects immunocompromised individuals. It presents with diverse neurological phenotypes, making its diagnosis challenging and frequently delayed. Clinical heterogeneity is compounded by the limitations of available diagnostic methods, and the use of corticosteroids can mask imaging and histological characteristics, further increasing diagnostic delay. We describe a case of a 68-year-old woman with a history of Hashimoto's thyroiditis who presented with rapidly progressive dementia (RPD). Initial testing revealed positive anti-thyroglobulin antibodies, leading to a suspicion of steroid-responsive encephalopathy associated with autoimmune thyroiditis. She was treated with corticosteroids, without clinical improvement. Brain magnetic resonance imaging (MRI) showed supratentorial hyperintense lesions on T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) sequences without diffusion restriction. Additionally, a nodular cerebellar lesion exhibited contrast enhancement and restricted diffusion. Cerebrospinal fluid (CSF) analysis, including cytology and flow cytometry, was unremarkable. The first brain biopsy performed four months after corticotherapy was inconclusive, revealing a non-specific inflammatory pattern. Only a second brain biopsy, performed nine months after corticosteroid therapy, confirmed the diagnosis of PCNSL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.